On March 8, 2023 Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, reported that the Supernus Pharmaceuticals management team will participate in the following March investor conferences (Press release, Supernus, MAR 8, 2023, View Source [SID1234628377]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Barclays Global Healthcare Conference
Date: Wednesday, March 15, 2023
Place: Loews Miami Beach Hotel, Miami, Fla.

Jefferies Biotech on the Bay Summit
Date: Thursday, March 16, 2023
Place: The 1 Hotel South Beach, Miami, Fla.

Investors interested in arranging a meeting with the Company’s management during these conferences should contact the respective conference coordinators.